Skip to main content

Investors

Il Gruppo Ulisse Biomed è un gruppo biotech integrato con tecnologie proprietarie, che sviluppa soluzioni diagnostiche, con un focus su salute pubblica, diagnostica distribuita e innovazione molecolare.

Investors

Il Gruppo Ulisse Biomed è un gruppo biotech intyegrato con tecnologie proprietarie, che sviluppa soluzioni diagnostiche, con un focus su salute pubblica, diagnostica distribuita e innovazione molecolare.

14 Agosto, 2021

Scientific publications

Impact of Full Vaccination with mRNA BNT162b2 on SARS-CoV-2 Infection: Genomic and Subgenomic Viral RNAs Detection in Nasopharyngeal Swab and Saliva of Health Care Workers


This study monitored 1898 health care workers after receiving full vaccination with the BNT162b2 mRNA vaccine. In a four-month period, only 10 workers tested positive for SARS-CoV-2, with a very low cumulative incidence (0.005%). The infections were mostly mild (60% of cases) or completely asymptomatic (40%). The study also compared the effectiveness of nasopharyngeal swabs and saliva samples in detecting the virus, finding that saliva is a viable alternative for surveillance. The results confirm the high efficacy of the vaccine, but underscore the importance of continued monitoring to identify asymptomatic carriers.

Microorganisms | 2021